.
R1881
(methylrienolone, 17ƒÀ-hydroxy-17ƒ¿-methylestra-4, 9, 11-triene-3-one) has been used for estimation of the binding to androgen (Bonne and Raynaud, 1975 (Menon et al., 1977 , Krieg et al., 1978 . Preparation of acetone-dried cytosol Cytosol was delipidized and precipitated by adding with9volumes of chilled acetone according to the method described by Ichii (1975) . The acetone-dried cytosol was suspended in TEM buffer, homogenized briefly, then spun, and the resultant supernatant was used for binding studies. single high affinity binding (Fig.1) . When binding analysis was performed with acetonedried cytosol, no high affinity binding was observed.
Cytosol was fractionated by the addition of ammonium sulfate into three fractions (0-30, 30-50, 50-70%) .
Whose binding properties were examined and high affinity binding was observed in the0-30% and 30-50% fractions (Fig.1) .
The binding capacity of the0-30% fraction was higher than that of the30-50% fraction when compared per unit of protein so that the 0-30% fraction seems to be rich in the 3H-R1881binding component .
Cytosol was incubated with 3H-R1881 in the presence or absence of an excess amount of radioinert R1881. After dextrancoated charcoal treatment to remove unbound steroid, an aliquot of the samples was applied to a Sephadex G-200column (Fig. KODAMA et al. 2). Sephadex chromatography of the cytosol prelabeled with 3H-dihydrotestosterone is also shown in the figure. Binding components to3H-R1881were eluted mostly in the void volume fraction (Vo fraction), followed by fraction of or shortly after the elution site of hIgG (IgG fraction) and fraction at the site of bovine serum albumin. chromatography of0-50% fraction of cytosol were examined (Fig.3) .
The Vo fraction showed a high affinity binding to 3H-R1881 , and binding affinity of the IgG fraction to this ligand seems to be lower than that of the Vo fraction.
The0-50% fraction prelabeled with either 3H-R1881or 3H-dihydrotestosterone was fractionated in sucrose density gradient centrifugation (Fig.4) .
In both cases, a small radioactive peak of8.8S was observed.
Inhibition of 3H-R1881 binding of cytosol by other steroids
Cytosol from human benign prostatic hypertrophy was incubated with various concentrations of 3H-R1881 in the presence or absence of10nm of dihydrotestosterone or cyproterone acetate (Fig.5) . Analysis of the binding showed a competitive type inhibition by these two steroids.
To examine the effect of various steroids on the binding of cytosol to 3H-R1881, cytosol was incubated with1nM of3H-R 1881supplemented with various concentrations (10-1000nM) of additives (Fig.6) . Progesterone, R5020and cyproterone acetate were potent inhibitors of the binding, but the inhibition by dihydrotestosterone and estradio1-17, 3 was rather weak.
As was shown in Fig.2 the addition of R1881did not evoke any effect on the binding of IgG fraction, the binding of the Vo fraction to 3H-dihydrotestosterone was inhibited by the R1881 supplement (Fig.7) .
Binding of nuclear extract to3H-R1881
The nuclear extract from tissues of human benign prostatic hypertrophy showed high affinity binding to both 3H-R1881and 3H-dihydrotestosterone (Fig .8) . Binding parameters for these two ligands were almost identical.
The nuclear extract was incubated with 1nM of 3H-R1881in the presence or absence of various concentrations (5-1000nM) a number of different steroids (Fig.9) .
Dihydrotestosterone inhibited the binding to 3H-R1881signi ficantly . Cyproterone acetate, R5020and estradio1-17p influenced the binding to a lesser extent. Therefore, inhibition of the binding of nuclear extract to 3H-R1881was quite different from that observed in the binding of cytosol.
Binding of 3H-R 1881-labeled cytosol to nuclei and extraction of the bound cytosol from nuclei by salt extraction Various amounts of cytosol prelabeled with 3H-R1881were incubated with purified nuclei. In one series of experiments, the cytosol concentration in each incubation tube was varied (variable protein) and in the other, cytosol content was adjusted equally by adding heat-inactivated cytosol (constant protein). An almost linear relationship between the amount of the prelabeled cytosol incubated and the amount bound to nuclei was observed in both series of experiments (Fig.10) .
Purified nuclei were incubated with3H- and10-100fmol/mg protein, respectively (Dube et al., 1976b , Menon et al., 1978 , Sirett and Grant, 1978and Cowan et al., 1977 . Similar binding parameters were also obtained in the present study.
Previous report showed that the binding ability of cytosol to dihydrotestosterone did not change after delipidization of cytosol by acetone (Kodama et al., 1977) . However, the high affinity binding component to R 1881was lost after treatment with acetone. Dihydrotestosterone-binding protein was concentrated in the precipitate of30-50% saturation of ammonium sulfate, but the R1881-binding component was observed in the0-30% ammonium sulfate fraction. Although these two proteins had an identical sedimentation coefficient of8.8S (Rosen et al., 1975 , Attramadal et al., 1975 , on Sephadex chromatography the R 1881-binding component was mainly located in the Vo fraction and the dihydrotestosterone-binding protein was detected in both Vo and IgG fractions. Inhibition by R1881of the binding of dihydrotestosterone, to components of the Vo fraction was observed in the present study, but from differences in physicochemical properties and steroid specificity it seems that the R1881-binding component is different from the dihydrotestosterone-binding protein. Snochowski et al.(1977) reported that binding of cytosol from human benign prostatic hypertrophy to R 1881 was inhibited significantly by dihydrotestosterone, while Asselin et al.,(1976) , Dube et al.,(1976a, b) and Cowan et al.,(1977) observed that the rate of inhibition of the binding by progestin was much higher than that of dihydrotestosterone. Menon et al.,(1978) 3H-R1881and 3H-dihydrotestosterone was extracted in almost the same manner as 0.4M KCl. However, the physiological significance of the salt-extractability of translocated cytosol component has been a matter of debate recently (Traish et al., 1977 ) and the problem is far from being solved. Although it may be considered that androgen action is mediated by androgenbinding proteins in human prostate, further studies concerning the role of these proteins are awaited.
